The Treatment of Oestrogen-Escaped Carcionoma of the Prostate with Estramustine Phosphate
- 1 December 1977
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 49 (7), 717-720
- https://doi.org/10.1111/j.1464-410x.1977.tb04559.x
Abstract
30 patients with oestrogen-escaped carcinoma of the prostate have been treated with estramustine phosphate (Estracyt). 27% showed a partial objective response and 33% had a subjective response. The terms used for defining a response are challenged and it is recommended that comparative controlled trials are necessary to judge the place of this drug in the management of advanced prostatic cancer.Keywords
This publication has 4 references indexed in Scilit:
- Treatment of Advanced Carcinoma of the Prostate with Estramustine PhosphateBritish Journal of Urology, 1977
- Extended Therapy of Stage D Carcinoma of the Prostate with Oral Estramustine PhosphateJournal of Urology, 1976
- Adjuvant therapy—Theory, practice, and potential. The james ewing lectureCancer, 1976
- Treatment of Advanced Prostatic Carcinoma with Estracyt: A Preliminary ReportScandinavian Journal of Urology and Nephrology, 1971